Your session is about to expire
← Back to Search
ALN-KHK for Type 2 Diabetes
Study Summary
This trial tests how safe and effective a drug is and how it works in the body when given in single or multiple doses.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- Your body mass index (BMI) is between 27 and 34.9.I have a history of either Type 1 or Type 2 diabetes.My thyroid condition has been stable with no changes for at least 4 months.My BMI is between 32 and 39.9, I have type 2 diabetes, and my HbA1c is between 7.5% and 10%.You have a history of type 1 diabetes.You have used an experimental drug in the last 30 days.I was diagnosed with type 2 diabetes less than 8 years ago.
- Group 1: Part B: ALN-KHK
- Group 2: Part B: Placebo
- Group 3: Part A: ALN-KHK
- Group 4: Part A: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment presently open for enrollment?
"According to clinicaltrials.gov, this experiment is searching for participants with the most recent update being made on March 7th of 2023. The trial was initially posted three months prior, in the first days of March."
Are candidates aged 45 and above eligible for this trial?
"This research study requires participants to fall within the age bracket of 18 and 65. Additionally, there are 244 trials for children under 18 years old and 1282 trials for senior citizens over 65."
What criteria must be fulfilled for someone to join this research?
"Patients with type 2 diabetes who fall between the age brackets of 18 to 65 can be admitted into this clinical trial. A total of 160 people are anticipated to take part in the study."
How many participants are encompassed in this clinical investigation?
"Affirmative, clinicaltrials.gov attests to the ongoing recruitment of patients for this trial which was initially posted on March 1st 2023 and most recently updated on July 3rd 2023. 160 participants must be located from a single centre."
Share this study with friends
Copy Link
Messenger